SCHEMBL23966516

SCHEMBL23966516

CCOC(=O)/C=C1\OC(=O)c2cccc(Br)c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.41
MAPT P10636 6/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
HSD17B10 Q99714 3/20 0.40
USP2 O75604 2/20 0.40
POLB P06746 2/20 0.40
GAA P10253 1/20 0.40
PKM P14618 1/20 0.40
GLA P06280 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
TYMS P04818 2/20 0.38
MAPK1 P28482 3/20 0.37
TSHR P16473 2/20 0.37
ALOX5 P09917 1/20 0.37
LMNA P02545 4/20 0.36
MDM2 Q00987 1/20 0.36
KDM4E B2RXH2 2/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5009486 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL13775156 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL9234683 0.82 ALDH1A1 (0.56) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL23908897 0.79 CA1 (0.40) ALDH1A1KMT2AMEN1HSD17B10TDP1
SCHEMBL23966494 0.76 ALDH1A1 (0.41) ALDH1A1MAPTKMT2AMEN1GLA
SCHEMBL23914627 0.74 MAPK1 (0.38) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL23966517 0.74 ALDH1A1 (0.40) ALDH1A1MAPTKMT2AMEN1POLB
SCHEMBL9674944 0.71 ALDH1A1 (0.38) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL9674953 0.71 ALDH1A1 (0.38) ALDH1A1MAPTKMT2AMEN1HSD17B10
SCHEMBL24662339 0.69 CTDSP1 (0.43) ALDH1A1MAPTKMT2AMEN1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed
CN-110869359-A Novel compounds and pharmaceutical compositions thereof for the treatment of fibrosis 加拉帕戈斯股份有限公司 2020-03-06 CN disclosed